Oxaliplatin, irinotecan and capecitabine for first line treatment of advanced metastatic colorectal cancer (CRC): A phase I-II trial by the Swiss Group for Clinical Cancer Research (SAKK 41/03)
ANNALS OF ONCOLOGY（2008）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要